Chu Yu-Waye
SEC insider (Form 3/4/5 filer). CIK 0001854586. Chief Medical Officer at CytomX Therapeutics, Inc. (CTMX). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Chu Yu-Waye has filed insider reports for
- CytomX Therapeutics, Inc. (CTMX): Officer, Chief Medical Officer
Chu Yu-Waye
CIK: 0001854586
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CytomX Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 17, 2026CTMX
CytomX Therapeutics, Inc.
SaleDirect21.3K shares at avg. $6.42$137K - Feb 2, 2026CTMX
CytomX Therapeutics, Inc.
AwardDirect75K shares- - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
87.5K shares- - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectPerformance Stock Units (PSUs)
43.8K shares- - Mar 18, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect4K shares at avg. $0.60$2K - Feb 4, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirect57.5K shares- - Feb 4, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirect56K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 | CTMX CytomX Therapeutics, Inc. | Sale | 21,279 | $6.42 | $136,675 | Direct |
| Feb 2, 2026 | CTMX CytomX Therapeutics, Inc. | Award | 75,000 | - | $0 | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Stock Option (Right to Buy) | 87,500 | - | - | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Performance Stock Units (PSUs) | 43,750 | - | - | Direct |
| Mar 18, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 4,025 | $0.60 | $2,411 | Direct |
| Feb 4, 2025 | CTMX CytomX Therapeutics, Inc. | Award | 57,500 | - | - | Direct |
| Feb 4, 2025 | CTMX CytomX Therapeutics, Inc. | Award | 56,000 | - | - | Direct |
1-7 of 7 transactions